PubMed (RefSeq) for id: 2030916873

Year	Number of Results
2001	1
2003	1
2004	1
2005	1
2009	1
2010	2
2011	2
2012	2
2015	1
2016	2
2018	2
2019	1
2024	0

1

Adamalysines as Biomarkers and a Potential Target of Therapy in Colorectal Cancer Patients: Preliminary Results.

Walkiewicz K, Strzelczyk J, Waniczek D, Biernacki K, Muc-Wierzgoń M, Copija A, Nowakowska-Zajdel E. Walkiewicz K, et al. Dis Markers. 2019 Sep 2;2019:5035234. doi: 10.1155/2019/5035234. eCollection 2019. Dis Markers. 2019. PMID: 31565100 Free PMC article.

2

Selective Inhibition of ADAM28 Suppresses Lung Carcinoma Cell Growth and Metastasis.

Mochizuki S, Shimoda M, Abe H, Miyamae Y, Kuramoto J, Aramaki-Hattori N, Ishii K, Ueno H, Miyakoshi A, Kojoh K, Okada Y. Mochizuki S, et al. Mol Cancer Ther. 2018 Nov;17(11):2427-2438. doi: 10.1158/1535-7163.MCT-17-1198. Epub 2018 Sep 6. Mol Cancer Ther. 2018. PMID: 30190423

3

SOX4, an epithelial-mesenchymal transition inducer, transactivates ADAM28 gene expression and co-localizes with ADAM28 at the invasive front of human breast and lung carcinomas.

Sasaki A, Abe H, Mochizuki S, Shimoda M, Okada Y. Sasaki A, et al. Pathol Int. 2018 Jun 7. doi: 10.1111/pin.12685. Online ahead of print. Pathol Int. 2018. PMID: 29882245

4

MicroRNA-552 enhances metastatic capacity of colorectal cancer cells by targeting a disintegrin and metalloprotease 28.

Wang J, Li H, Wang Y, Wang L, Yan X, Zhang D, Ma X, Du Y, Liu X, Yang Y. Wang J, et al. Oncotarget. 2016 Oct 25;7(43):70194-70210. doi: 10.18632/oncotarget.12169. Oncotarget. 2016. PMID: 27661126 Free PMC article.

5

ADAM23 is downregulated in side population and suppresses lung metastasis of lung carcinoma cells.

Ota M, Mochizuki S, Shimoda M, Abe H, Miyamae Y, Ishii K, Kimura H, Okada Y. Ota M, et al. Cancer Sci. 2016 Apr;107(4):433-43. doi: 10.1111/cas.12895. Epub 2016 Mar 16. Cancer Sci. 2016. PMID: 26800504 Free PMC article.

6

CXCL12 and ADAM23 hypermethylation are associated with advanced breast cancers.

Fridrichova I, Smolkova B, Kajabova V, Zmetakova I, Krivulcik T, Mego M, Cierna Z, Karaba M, Benca J, Pindak D, Bohac M, Repiska V, Danihel L. Fridrichova I, et al. Transl Res. 2015 Jun;165(6):717-30. doi: 10.1016/j.trsl.2014.12.006. Epub 2015 Jan 9. Transl Res. 2015. PMID: 25620615

7

Effect of ADAM28 on carcinoma cell metastasis by cleavage of von Willebrand factor.

Mochizuki S, Soejima K, Shimoda M, Abe H, Sasaki A, Okano HJ, Okano H, Okada Y. Mochizuki S, et al. J Natl Cancer Inst. 2012 Jun 20;104(12):906-22. doi: 10.1093/jnci/djs232. Epub 2012 May 25. J Natl Cancer Inst. 2012. PMID: 22636800

8

Baseline and decline of serum ADAM28 during chemotherapy of advanced non-small cell lung cancer: a probable predictive and prognostic factor.

Lv YL, Yuan DM, Wang QB, Zhan P, Luo L, Lv TF, Liu HB, Li YF, Wen J, Song Y. Lv YL, et al. Med Oncol. 2012 Dec;29(4):2633-9. doi: 10.1007/s12032-012-0180-5. Epub 2012 Feb 22. Med Oncol. 2012. PMID: 22354764

9

Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.

Gaudet P, Livstone MS, Lewis SE, Thomas PD. Gaudet P, et al. Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27. Brief Bioinform. 2011. PMID: 21873635 Free PMC article.

10

The expression of ADAM23 and its correlation with promoter methylation in non-small-cell lung carcinoma.

Hu C, Lv H, Pan G, Cao H, Deng Z, Hu C, Wen J, Zhou J. Hu C, et al. Int J Exp Pathol. 2011 Oct;92(5):333-9. doi: 10.1111/j.1365-2613.2011.00766.x. Epub 2011 Mar 23. Int J Exp Pathol. 2011. PMID: 21429053 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

17 results

Results by year